Insider Selling: Integer Holdings Co. (NYSE:ITGR) VP Sells 1,500 Shares of Stock

Integer Holdings Co. (NYSE:ITGR) VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total value of $171,000.00. Following the completion of the transaction, the vice president now directly owns 2,813 shares in the company, valued at $320,682. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Integer Price Performance

ITGR opened at $111.27 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. Integer Holdings Co. has a 52-week low of $69.40 and a 52-week high of $123.99. The stock has a market capitalization of $3.73 billion, a PE ratio of 38.50, a price-to-earnings-growth ratio of 1.62 and a beta of 1.12. The stock’s 50 day moving average price is $114.06 and its 200-day moving average price is $100.73.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analysts’ expectations of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.87 earnings per share. On average, equities research analysts predict that Integer Holdings Co. will post 5.27 EPS for the current year.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Integer by 0.4% in the third quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider’s stock worth $301,484,000 after purchasing an additional 15,300 shares during the period. Victory Capital Management Inc. grew its stake in Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider’s stock worth $128,041,000 after purchasing an additional 133,898 shares during the period. FMR LLC grew its stake in Integer by 12.8% in the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider’s stock worth $67,759,000 after purchasing an additional 97,851 shares during the period. Fuller & Thaler Asset Management Inc. grew its stake in Integer by 497.0% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider’s stock worth $42,065,000 after purchasing an additional 446,508 shares during the period. Finally, abrdn plc boosted its holdings in Integer by 0.6% in the fourth quarter. abrdn plc now owns 520,646 shares of the medical equipment provider’s stock worth $51,586,000 after acquiring an additional 3,013 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on ITGR shares. Bank of America raised Integer from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. KeyCorp lifted their price target on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 9th. CL King assumed coverage on Integer in a research note on Thursday, March 14th. They set a “buy” rating and a $137.00 target price on the stock. Finally, Benchmark reissued a “buy” rating and set a $130.00 target price on shares of Integer in a research note on Friday, April 26th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $120.50.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.